A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery
Key facts
- Who runs it
- University of Malaya
- Where
- Malaysia2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 74 people enrolled
- Started
- 6 Jan 2025
- Ended
- 31 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Palonosetron (Group P)
- Granisetron (Group G)
- Record updated
- 20 August 2026
Who can take part
- Age
- 10 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age: 10 years and above
- American Society of Anesthesiologists (ASA) class I-II
Who cannot take part
- History of gastro-esophageal reflux disease (GERD)/ other gastrointestinal diseases associated with vomiting
- History of motion sickness
- History of allergy to 5-HT3 (serotonin) receptor antagonists or dexamethasone
- History of nausea or vomiting withing 24 hours before surgery
- History of administration of antiemetics/ steroids/ psychoactive medications within 24 hours before the surgery
- History of cardiac arrhythmias
- Prolonged QT (QTc is prolonged if > 430ms in men or >450ms in women)
- Active smoker
- Obesity with body mass index (BMI) of 34 and above
- Body weight of less than 30kg
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this clinical trial is to compare the effectiveness of two Serotonin (5- HT3) receptor antagonist, palonosetron and granisetron, administered along with dexamethasone as a preventive measure against early and delayed postoperative nausea and vomiting (PONV) in adult and adolescent patients with idiopathic scoliosis (IS) undergoing posterior spinal fusion (PSF) surgery under total intravenous anesthesia (TIVA).
Read full original descriptionShow less
The main questions the study aims to answer are:
How effective is palonosetron compared to granisetron, when both combined with dexamethasone, in preventing PONV after scoliosis surgery? Are there any differences in the need for rescue antiemetics, occurrence of adverse effects related to the study drugs, and patient satisfaction between the two treatment groups? Participants in the study will be randomly assigned to receive either palonosetron or granisetron in addition to dexamethasone as part of their anesthesia and antiemetic regimen. The incidence and/ or severity of nausea, vomiting and retching will be assessed at 1 hour, 4 hours, 12 hours, 24 hours and 48 hours after surgery.
The 2 groups in the trial
- Palonosetron Group (Group P)Treatment being tested
Group P will receive a stat dose of IV palonosetron 1.5mcg/kg diluted in a 5ml preparation of normal saline 0.9% prior to the commencement of general anaesthesia. At the start of wound closure, Group P will receive a 5ml preparation of normal saline 0.9% as a placebo.
Treatment: Palonosetron (Group P)
- Granisetron Group (Group G)Existing treatment, for comparison
Group G will receive a 5ml preparation of normal saline 0.9% as placebo prior to commencement of general anaesthesia. At the start of wound closure, a stat dose of IV granisetron 1mg in 5ml preparation will be administered.
Treatment: Granisetron (Group G)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Comparison Between Palonosetron Versus Granisetron As Postoperative Nausea and Vomiting Prophylaxis In Idiopathic Scoliosis Surgery: A Randomized Control Trial
- Record updated
- 20 August 2026